Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Contraception Clinical Trial
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling, Phase III
Updated: 4/13/2016
Clinical Research Facility
mi
from
Webster, TX
Click here to add this to my saved trials
Parkinson Disease Clinical Trial
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Iowa Dept. of Neurology
mi
from
Iowa city, IA
Click here to add this to my saved trials
Parkinson Disease Clinical Trial
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Kansas University Medical Center - Department of Neurology
mi
from
Kansas City, KS
Click here to add this to my saved trials
Parkinson Disease Clinical Trial
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Sentara Neuroscience Institute
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 7/6/2016
Wellness Clinical Research Associates
mi
from
McKinney, TX
Click here to add this to my saved trials
Pneumonia, Bacterial Clinical Trial
A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia
Status: Enrolling, Phase I
Updated: 12/7/2015
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Vincent's/Peter Mac
mi
from
Fitzroy,
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Meridian Health System
mi
from
Neptune, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
The Tweed Hospital
mi
from
Tweed Heads,
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Cancer Clinical Trial
GSK3174998 Alone or With Pembrolizumab in Subjects With Advanced Solid Tumors (ENGAGE-1)
Status: Enrolling, Phase I
Updated: 12/31/1969
GSK Investigational Site
mi
from
Toronto,
Click here to add this to my saved trials
Hemophilia Clinical Trial
ATHN 2: Factor Switching Study
Status: Enrolling, Phase
Updated: 12/31/1969
University of Michigan Hemophilia and Coagulation Disorders Program
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Acute Antibody-Mediated Rejection (AMR) Clinical Trial
A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant
Status: Enrolling, Phase III
Updated: 12/31/1969
NYU Longone Medical Center
mi
from
White Plains, NY
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Axiom Clinical Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Lupus Nephritis Clinical Trial
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Lupus Nephritis Clinical Trial
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Lupus Nephritis Clinical Trial
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Lupus Nephritis Clinical Trial
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Lupus Nephritis Clinical Trial
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
TriHealth Hatton Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
University of Tennessee Health Science Center/Le Bonheur
mi
from
Memphis, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
Children's Omaha
mi
from
Omaha, NE
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
Status: Enrolling, Phase IV
Updated: 4/3/2018
One Health Cardiology, Owensboro Health, Inc.
mi
from
Owensboro, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
Status: Enrolling, Phase IV
Updated: 4/3/2018
St. Louis Heart and Vascular
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Aortic Aneurysm Abdominal Clinical Trial
Zenith® p-Branch® Endovascular Graft Pivotal Study
Status: Enrolling
Updated: 12/31/1969
University of Alabama Birmingham Hosptial
mi
from
Birmingham, AL
Click here to add this to my saved trials
Aortic Aneurysm Abdominal Clinical Trial
Zenith® p-Branch® Endovascular Graft Pivotal Study
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital Plaza
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
The Johns Hopkins Hospital Department of Pharmacy Services
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Center for Clinical Investigation, Brigham and Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigational Drug Services
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Downstate Medical Center State Univ of NY HLTH SCI CTR PHMCY
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Hermann/UT Cancer Center - Texas Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital of Philadelphia, Investigational Drug Service
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Howard University Center for Sickle Cell disease
mi
from
Washington DC,
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
15
mi
from
Concord,
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Mentor, OH
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
Clinical Research Facility
mi
from
Hermitage, PA
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Enrolling, Phase II
Updated: 2/13/2018
Advocate Children's Medical Group
mi
from
Chicago, IL
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Ark Clinical Research
mi
from
Long Beach, CA
Click here to add this to my saved trials
RLS Clinical Trial
An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Status: Enrolling, Phase IV
Updated: 12/31/1969
The Sleep Center at the Childrens Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
RLS Clinical Trial
An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Status: Enrolling, Phase IV
Updated: 12/31/1969
Mercy Health — Children's Hospital Pulmonary & Sleep Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
MedResearch, Inc.
mi
from
El Paso, TX
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
UCSF Fresno Clinical Research Center
mi
from
Fresno, CA
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Digestive Health Specialist Research Institute
mi
from
Lakewood Ranch, FL
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Meridien Research, Inc.
mi
from
Maitland, FL
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Bon Secours Liver Institute of Virginia
mi
from
Richmond, VA
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Louis University, Gastroenterology and Hepatology, Clinical Research Unit
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
West Michigan Clinical Research
mi
from
Wyoming, MI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Mid Florida Hematology and Oncology Centers
mi
from
Orange City, FL
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Anchorage Associates in Radiation Medicine
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Wellmont Medical Associates-Bristol
mi
from
Bristol, VA
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Great Lakes Cancer Management Specialists-Doctors Park
mi
from
East China Township, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Sanford Broadway Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Grand Valley Oncology
mi
from
Grand Junction, CO
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
PeaceHealth Saint John Medical Center
mi
from
Longview, WA
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Saint Mary's Oncology/Hematology Associates of Marlette
mi
from
Marlette, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Mercy Health Perrysburg Cancer Center
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Hope Cancer Center
mi
from
Pontiac, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
21st Century Oncology-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
ProHealth Waukesha Memorial Hospital
mi
from
Waukesha, WI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Huron Gastroenterology PC
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation
Status: Enrolling, Phase I
Updated: 6/21/2016
UZ Leuven
mi
from
Leuven,
Click here to add this to my saved trials
Thromboembolism Clinical Trial
Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates
Status: Enrolling, Phase I, II
Updated: 12/21/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Thromboembolism Clinical Trial
Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates
Status: Enrolling, Phase I, II
Updated: 12/21/2017
Research Site
mi
from
Parkville,
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pensacola, FL
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Peoria, IL
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Anchorage Associates in Radiation Medicine
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
PCR Oncology
mi
from
Arroyo Grande, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Broadway Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Ann M Wierman MD LTD
mi
from
Las Vegas, NV
Click here to add this to my saved trials